These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6363031)

  • 1. [Serum antibodies against Ixodes ricinus Spirochaeta in acrodermatitis chronica atrophicans (Herxheimer)].
    Ackermann R; Boisten HP; Kabatzki J; Runne U; Krüger K; Herrmann WP
    Dtsch Med Wochenschr; 1984 Jan; 109(1):6-10. PubMed ID: 6363031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays.
    Asbrink E; Hovmark A; Hederstedt B
    Acta Derm Venereol; 1985; 65(6):509-14. PubMed ID: 2420115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ixodes ricinus spirochete and European erythema chronicum migrans disease.
    Ackermann R; Kabatzki J; Boisten HP; Steere AC; Grodzicki RL; Hartung S; Runne U
    Yale J Biol Med; 1984; 57(4):573-80. PubMed ID: 6393609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer.
    Asbrink E; Hovmark A; Hederstedt B
    Acta Derm Venereol; 1984; 64(6):506-12. PubMed ID: 6084922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological diagnosis of erythema migrans disease and related disorders.
    Wilske B; Schierz G; Preac-Mursic V; Weber K; Pfister HW; Einhäupl K
    Infection; 1984; 12(5):331-7. PubMed ID: 6392104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical aspects and etiology of acrodermatitis chronica atrophicans].
    Weber K; Schierz G; Wilske B; Preac-Mursic V
    Hautarzt; 1984 Nov; 35(11):571-7. PubMed ID: 6394553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etiology of acrodermatitis chronica atrophicans and erythema chronicum migrans].
    Herrmann WP
    Z Hautkr; 1986 Apr; 61(8):515-21. PubMed ID: 3521114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acrodermatitis chronica atrophicans].
    Wittmann D; Heppt M; Ruzicka T
    MMW Fortschr Med; 2016 Mar; 158(6):64, 66-7. PubMed ID: 27084166
    [No Abstract]   [Full Text] [Related]  

  • 10. [Borreliosis--still a diagnostic labyrinth].
    Marsch WC; Muckelmann R
    Z Hautkr; 1985 Aug; 60(15):1241-2. PubMed ID: 4049991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ixodes ricinus Spirochaeta: probable pathogen responsible for Herxheimer's acrodermatitis chronica atrophicans].
    Steigleder GK
    Dtsch Med Wochenschr; 1984 Jan; 109(1):3-5. PubMed ID: 6363030
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes.
    Asbrink E
    Acta Derm Venereol Suppl (Stockh); 1985; 118():1-63. PubMed ID: 3901647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiology of erythema migrans disease and Lyme disease. Review and results of personal study].
    Neubert U
    Hautarzt; 1984 Nov; 35(11):563-70. PubMed ID: 6519987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Borrelia burgdorferi-specific serum IgG antibody levels in patients treated for acrodermatitis chronica atrophicans.
    Olsson I; Asbrink E; von Stedingk M; von Stedingk LV
    Acta Derm Venereol; 1994 Nov; 74(6):424-8. PubMed ID: 7701871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans.
    Hulshof MM; Vandenbroucke JP; Nohlmans LM; Spanjaard L; Bavinck JN; Dijkmans BA
    Arch Dermatol; 1997 Jan; 133(1):33-7. PubMed ID: 9006370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The spirochetal etiology of erythema chronicum migrans and of meningo-polyneuritis Garin-Bujadoux-Bannwarth].
    Ackermann R
    Z Hautkr; 1983 Nov; 58(22):1616, 1619-21. PubMed ID: 6659638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of serum antibodies against Borrelia burgdorferi with some commercially available serological tests.
    Melby K; Steinbakk M; Jensenius M; Figenschau KJ
    NIPH Ann; 1990 Dec; 13(2):37-44. PubMed ID: 2093855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythema migrans borreliosis in the Federal Republic of Germany. Epidemiology and clinical aspects].
    Schmidt R; Kabatzki J; Hartung S; Ackermann R
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1803-7. PubMed ID: 3905325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
    Glatz M; Golestani M; Kerl H; Müllegger RR
    Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans.
    Müllegger RR; McHugh G; Ruthazer R; Binder B; Kerl H; Steere AC
    J Invest Dermatol; 2000 Dec; 115(6):1115-23. PubMed ID: 11121150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.